Billy Costa talks with Dr. Matt Frigault and oncology social worker Lauren DeMarco to learn more about the latest in CAR T-cell therapies and what it all means for patients.

1 of 1

  • Matthew Frigault, MD

    • Administrative Director, Cellular Therapy Service
    • Assistant Professor of Medicine, Harvard Medical School

Related Programs

Type

Centers and Departments

Topics